Search results
Results from the WOW.Com Content Network
QRISK3 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial ...
The main aim of screening is to identify risk factors early and adopt preventive measures to reduce morbidity and mortality. [ 1 ] [ 2 ] Early identification of risk factors can lead to timely interventions, such as lifestyle changes, medications, or surgical treatment.
The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. [5] It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.
The project has the support of the government, the life sciences industry, the NHS, and charities such as Alzheimer's Society, British Heart Foundation, and Cancer Research UK. [ 2 ] £79 million was provided by the UK government via the UK Research and Innovation body, and in early 2022 a further £100 million was expected from the life ...
British Heart Foundation; British Homeopathic Association; The British Liver Trust; British Nutrition Foundation; British Occupational Hygiene Society; British Pregnancy Advisory Service; British Red Cross; British Skin Foundation; British Society for Nanomedicine; British Society for Surgery of the Hand; British Thyroid Foundation; Brittle ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The Heart Protection Study was a randomized controlled trial run by the Clinical Trial Service Unit, and funded by the Medical Research Council (MRC) and the British Heart Foundation (BHF) in the United Kingdom.
Armitage led the 1999 Medical Research Council and British Heart Foundation Heart Protection Study, which included 20,000 participants. [6] The study is the largest that investigates the use of statins to prevent cardiovascular disease. [6]